🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Role of HbA1c in Predicting Adverse Pregnancy Outcomes

Recruitingn/aAges any - anyFemaleNational University of Malaysia
NCT06676254 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to determine the reference value of HbA1c that can be used to predict adverse pregnancy outcomes. These adverse outcomes include LGA fetus, shoulder dystocia, caesarean section, pre-term birth, pre-eclampsia and fetal neonatal hypoglycaemia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Pregnant woman with singleton pregnancy * Confirmed diagnosis of GDM based on Malaysia CPG (≥5.1/7.8) * HbA1c level taken at least once at any time during the pregnancy * Delivery after 28 weeks gestation Exclusion Criteria: * Major fetal anomaly * Haemoglobin level of ≤9 g/dL (moderate or severe anaemia in pregnancy) * Women with autoimmune diseases * Overt diabetes or pre-existing diabetes
💊

What it tests

  • Not listed
📍

Where

1 site
Department of Obstetrics & Gynaecology, Hospital Canselor Tuanku Muhriz
Cheras, Malaysia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy